Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹20.91
▼ 0.02
(0.10%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical ... | 31 Aug 2026 | 20.76% | 1,64,106 | ₹32.57 Cr | Equity | Pharmaceuticals | |
 Divis Laboratories Ltd | 31 Aug 2026 | 11.88% | 19,688 | ₹18.64 Cr | Equity | Pharmaceuticals | |
 Cipla Ltd | 31 Aug 2026 | 7.83% | 87,200 | ₹12.29 Cr | Equity | Pharmaceuticals | |
 Laurus Labs Ltd | 31 Aug 2026 | 7.36% | 60,292 | ₹11.55 Cr | Equity | Pharmaceuticals | |
 Torrent Pharmaceuti... | 31 Aug 2026 | 7.34% | 22,724 | ₹11.51 Cr | Equity | Pharmaceuticals | |
| Dr Reddys Laborator... | 31 Aug 2026 | 6.95% | 94,471 | ₹10.91 Cr | Equity | Pharmaceuticals | |
| Lupin Ltd | 31 Aug 2026 | 5.25% | 37,631 | ₹8.24 Cr | Equity | Pharmaceuticals | |
 Aurobindo Pharma Ltd | 31 Aug 2026 | 4.69% | 42,891 | ₹7.36 Cr | Equity | Pharmaceuticals | |
 Glenmark Pharmaceut... | 31 Aug 2026 | 3.69% | 23,325 | ₹5.78 Cr | Equity | Pharmaceuticals | |
| Alkem Laboratories Ltd | 31 Aug 2026 | 3.08% | 9,056 | ₹4.83 Cr | Equity | Pharmaceuticals |
Funds in the same category by AUM
You can invest in ICICI Pru Nifty Pharma Index Fund-Dir (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹1,000 and the minimum SIP amount is ₹1,000.
The latest NAV of ICICI Pru Nifty Pharma Index Fund-Dir (G) is ₹20.91.
ICICI Pru Nifty Pharma Index Fund-Dir (G) manages assets worth ₹156.88 Cr.
The expense ratio of ICICI Pru Nifty Pharma Index Fund-Dir (G) is 0.52%.
The exit load applicable on ICICI Pru Nifty Pharma Index Fund-Dir (G) is Nil..
As per the riskometer, ICICI Pru Nifty Pharma Index Fund-Dir (G) carries Very High risk.
ICICI Pru Nifty Pharma Index Fund-Dir (G) is managed by ICICI Prudential Mutual Fund.
ICICI Pru Nifty Pharma Index Fund-Dir (G) belongs to the Index Fund category.
ICICI Pru Nifty Pharma Index Fund-Dir (G) is benchmarked against the Nifty Pharma TRI.
ICICI Pru Nifty Pharma Index Fund-Dir (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
ICICI Pru Nifty Pharma Index Fund-Dir (G) was launched on 14 Dec 2022.
After the initial investment, you can invest in ICICI Pru Nifty Pharma Index Fund-Dir (G) in further multiples of ₹1,000.
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
14 Dec 2022
₹156.88 Cr
₹20.91
₹1,000
₹1,000
Very High
0.52%
-0.61
1.00
0.99
4.61
0.98
0.16
0.30
Nil.
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
| Sai Life Sciences Ltd | Biotechnology | Bought | 31 Jul 2026 | 1.84% | ₹2.72 Cr | 20,658 | Equity | EQUITY | |
 J B Chemicals & Pha... | Pharmaceuticals -... | Sold | 30 Jun 2026 | 2.03% | ₹2.76 Cr | 12,028 | Equity | EQUITY |
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 DSP Nifty 50 Equal Weight Ind... | -1.20% | 10.90% | 0.48% | ₹2,671.44 Cr | -0.45 | 0.61 | Very High | |
 HDFC NIFTY50 Equal Weight Ind... | -1.31% | 10.86% | 0.46% | ₹1,808.73 Cr | -0.49 | 0.61 | Very High | |
 Bandhan Nifty100 Low Volatili... | -5.10% | 8.76% | 0.46% | ₹1,604.25 Cr | -0.66 | 0.47 | Very High | |
 SBI Nifty Midcap 150 Index Fu... | 4.72% | 14.64% | 0.46% | ₹1,292.32 Cr | -0.39 | 0.69 | Very High | |
 Nippon India Nifty Alpha Low ... | -2.00% | 9.76% | 0.63% | ₹1,291.68 Cr | -0.66 | 0.49 | Very High | |
| SBI Nifty50 Equal Weight Inde... | -1.33% | — | 0.49% | ₹1,064.35 Cr | -0.58 | 0.27 | Very High | |
| ICICI Pru Nifty Pharma Index ... | 22.01% | 21.48% | 0.52% | ₹156.88 Cr | -0.61 | 0.99 | Very High |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 UTI-Nifty 50 Index Fund -... | UTI Mutual Fund | ₹162.96 | ₹29,485.43 Cr | 0.25% | -7.12% | 6.43% | 6.27% | |
| HDFC Nifty 50 Index Fund ... | HDFC Mutual Fund | ₹226.50 | ₹23,783.91 Cr | 0.29% | -7.20% | 6.38% | 6.22% | |
| ICICI Pru Nifty 50 Index ... | ICICI Prudential Mutual Fund | ₹244.96 | ₹17,253.52 Cr | 0.24% | -7.15% | 6.38% | 6.23% | |
| SBI Nifty Index Fund - Di... | SBI Mutual Fund | ₹216.54 | ₹13,927.86 Cr | 0.24% | -7.20% | 6.39% | 6.23% | |
| ICICI Prudential Mutual Fund | ₹66.82 | ₹10,116.69 Cr | 0.38% | 4.14% | 16.79% | 11.07% | |
| ICICI Pru Nifty Pharma In... | ICICI Prudential Mutual Fund | ₹20.91 | ₹156.88 Cr | 0.52% | 22.01% | 21.48% | — |